Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability

BACKGROUND: Neutralizing antibodies (NAb) to interferon-beta (IFN-β) are associated with reduced bioactivity and efficacy of IFN-β in multiple sclerosis (MS). The myxovirus resistance protein A (MxA) gene expression is one of the most appropriate markers of biological activity of exogenous IFN-β. We...

Full description

Saved in:
Bibliographic Details
Published in:Med Sci Monit
Main Authors: Giedraitiene, Natasa, Kaubrys, Gintaras, Kizlaitiene, Rasa, Bagdonatė, Loreta, Griskevicius, Laimonas, Valceckiene, Vilma, Stoskus, Mindaugas
Format: Artigo
Language:Inglês
Published: International Scientific Literature, Inc. 2015
Subjects:
Clinical Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4456985/
https://ncbi.nlm.nih.gov/pubmed/26009248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.894119
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items